Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A...

Area of Science:

• Hepatology
• Oncology
• Diagnostic Accuracy Studies

Background:

• Patients with Hepatitis C Virus (HCV) face an elevated risk of developing hepatocellular carcinoma (HCC).
• The diagnostic value of serum alpha-fetoprotein (AFP) for HCC detection in HCV-infected individuals remains uncertain.

Purpose of the Study:

• To determine the test characteristics of alpha-fetoprotein (AFP) for diagnosing hepatocellular carcinoma (HCC) in patients with Hepatitis C Virus (HCV).

Main Methods:

• A comprehensive literature search of MEDLINE (1966-2002) was conducted for studies on AFP's test characteristics in HCC detection.
• Included studies reported sensitivity and specificity for AFP in HCV patients; excluded studies had ambiguous hepatitis causes or insufficient HCV patient populations.
• Quality of evidence was assessed, and test characteristics were abstracted and calculated.

Main Results:

• Analysis included five studies, revealing limited overall evidence quality.
• Commonly reported test characteristics (AFP > 20 microg/L cutoff) showed sensitivity (41%-65%), specificity (80%-94%), positive likelihood ratios (3.1-6.8), and negative likelihood ratios (0.4-0.6).
• Concerns regarding study design and gold standard application were noted, potentially overestimating diagnostic accuracy.

Conclusions:

• High-quality data are scarce, necessitating rigorous studies with accepted gold standards for evaluating AFP and other HCC diagnostic tests in HCV patients.
• Even with optimistic estimates, the utility of AFP for hepatocellular carcinoma detection in HCV-infected individuals appears limited.